Press release
Delpharm and the Famar Group announce the acquisition by Delpharm of 5 manufacturing sites in France, Canada and the Netherlands
Paris, November 18, 2019 – Delpharm and the Famar Group are pleased to announce the acquisition by Delpharm of 5 manufacturing sites belonging to Famar, in France, Canada and the Netherlands.
The transaction signed today covers the French sites located in Orléans (Loiret), L’Aigle (Orne) and Saint-Rémy-sur-Avre (Eure-et-Loire), as well as the Montreal site in Canada and that of Bladel in the Netherlands.
The group of 5 sites represents a turnover of 250M€ and 1,300 employees.
Patrick Puy, President of Famar: « This acquisition by Delpharm, a reputable CDMO, represents a great opportunity for the 1300 Famar colleagues and will allow the sites to foresee a fruitful and sustainable future. »
Sébastien Aguettant, President of Delpharm: « With an headcount of 4700 people working on 17 manufacturing sites, Delpharm is reaching a new level and is now part of the top 5 CDMOs worldwide. »
Delpharm and the Famar Group wish to thank all the stakeholders who worked hard to make this deal happen, especially the French authorities, for their positive involvement.
About Delpharm
Delpharm is a European leader in contract manufacturing and development of medicines for pharmaceutical laboratories. It owns 17 manufacturing plants (12 in France, 2 in Italy, 1 in Belgium, 1 in the Netherlands and 1 in Canada) providing the majority of dosage forms available on the market: tablets, syrups, bottles, vials, etc.
Including the revenues of the 5 additional sites, Delpharm will generate 750M€ in turnover and continues to be wholly-owned by its management.
For more information, please visit our website: www.delpharm.com
About Famar
Famar is a leading provider of Contract Manufacturing and Development Services to the Pharmaceutical and Health & Beauty industry.
From development to production and distribution, Famar’s services enable the Health and Personal Care industry to deliver innovative and accessible solutions for the improvement of patients & consumers’ lives.
The group supplies a wide range of more than 1800 products to a broad customer base in 125 international markets.
Media contacts
Delpharm: Stéphane Lepeu +33(0)6.07.57.70.15 – stephane.lepeu@delpharm.com
Famar: Catherine Kuttner +33 (0)1.44.70.65.02 – c.kuttner@famar-group.com